NEWBURYPORT, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that R.
NEWBURYPORT, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly, President Mitchell C. Rock, and Chief Financial Officer Ron Lataille will participate in the upcoming Piper Sandler 37th Annual Healthcare Conference to be held in New York City December 1-4, 2025. UFP's presentation is scheduled to begin at 8:10 AM on Wednesday, December 3rd. A live audio webcast of UFP's presentation will be available here.
UFP Industries is upgraded to a soft "Buy" after a 19% stock decline and improved valuation. UFPI's fundamentals have weakened due to industry headwinds, with revenue, profits, and cash flows all down across segments. Despite near-term challenges, UFPI's strong balance sheet and cheap valuation versus peers position it well for a future rebound.
Investors need to pay close attention to UFPI stock based on the movements in the options market lately.
GRAND RAPIDS, Mich.--(BUSINESS WIRE)--UFP Factory Built introduces BRAWN™, a brand of structural and custom components engineered to make factory-built homes, RVs, and cargo trailers stronger, more reliable, and easier to build. Backed by UFP Industries' decades of experience in sourcing, engineering, and manufacturing expertise, BRAWN delivers performance, precision, and peace of mind. BRAWN delivers high-performance structural components, value-added framing lumber, trusses, roofs, walls, flo.
UFP Technologies, Inc. ( UFPT ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Ronald Lataille - CFO, Senior VP & Treasurer R. Bailly - CEO & Chairman Conference Call Participants Justin Ages - CJS Securities, Inc. Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Maxwell Michaelis - Lake Street Capital Markets, LLC, Research Division Noah Lewis - Raymond James & Associates, Inc., Research Division Presentation Operator Good day, and welcome to the UFP Technologies Third Quarter 2025 Earnings Conference Call.
NEWBURYPORT, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $16.4 million or $2.11 per diluted common share outstanding for its third quarter ended September 30, 2025, the same as in Q3 of 2024. Adjusted earnings per diluted share outstanding for the third quarter ended September 30, 2025, was $2.39. Sales for the third quarter were $154.6 million compared to sales of $145.2 million in the third quarter of 2024. Net income for the nine-month period ended September 30, 2025, was $50.7 million or $6.52 per diluted common share outstanding compared to net income of $42.6 million or $5.49 per diluted common share outstanding for the same period in 2024. Sales for the nine-month period ended September 30, 2025, were $453.9 million compared to sales of $360.4 million for the same period in 2024. Throughout this news release, reference is made to non-GAAP measures including organic sales growth, adjusted gross margin, adjusted operating income, adjusted SG&A, adjusted net income and EPS, and EBITDA and adjusted EBITDA. Please see “Non-GAAP Financial Information” at the end of this news release.
D.A. Davidson and CO. reduced its stake in UFP Industries, Inc. (NASDAQ: UFPI) by 10.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,337 shares of the construction company's stock after selling 530 shares during the period. D.A. Davidson
GRAND RAPIDS, Mich.--(BUSINESS WIRE)--UFP Industries, Inc. (Nasdaq: UFPI) a leading manufacturer focused on delivering value-added products across its Retail, Packaging, and Construction segments reported results for the third quarter 2025. Net Sales of $1.56 billion decreased by 5 percent due to a 1 percent decrease in price and a 4 percent decline in organic units. Diluted earnings per share of $1.29 compared to $1.64 a year ago. Net earnings attributable to controlling interest of $76 millio.
NEWBURYPORT, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that the Company plans to report results for the third quarter on Monday, November 3rd, after the close of the stock market.
